ERAPs (ERAP1 and ERAP2) are emerging therapeutic targets associated with multiple autoimmune diseases.Genomics will assemble the largest available genetic resource to evaluate how ERAP variants ...
Genomics, a science-led techbio company using large-scale genetic information to accelerate drug discovery and development and develop innovative precision healthcare tools, today announced a ...
The dismantling of public health through NIH funding cuts, CDC censorship and Medicaid rollbacks is a deliberate attack on ...
Financing led by Sofinnova Investments and co-led by Forbion and Novo Holdings Proceeds to advance lead immunology program COL-5671, a potential first-in-class, oral once-daily therapy, across a range ...
Conjugation of universal, functionally de-targeted OneAAVTM capsid provides on-demand specificity and scalabilityto address ...
Financing led by Sofinnova Investments and co-led by Forbion and Novo HoldingsProceeds to advance lead immunology program COL-5671, a potential ...
Positive Full Results from Phase 1a Trial of Anti-TSLP/IL-4Rα Bispecific Antibody ATI-052 Exceed Aclaris’ Target Profile, ...
Oral steroids and painkillers both relieve discomfort but work very differently. While steroids suppress inflammation and ...
Norfolk and Brantford-Brant are unaware doctors do not automatically report mandatory childhood vaccinations to the health ...
Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Scams: Who they happen to and how. Hear true stories on The ...
A growing movement claims social media is “addictive,” and lawmakers are treating it as settled science. But the evidence is ...
Nanozymes, a novel class of nanomaterials with enzyme-like activities, have emerged as a promising tool for treating various diseases by modulating reactive oxygen species (ROS). Nanozymes can mimic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results